AU7922300A - Diagnosis kit, method and microarray for determining human detoxification capacity - Google Patents

Diagnosis kit, method and microarray for determining human detoxification capacity

Info

Publication number
AU7922300A
AU7922300A AU79223/00A AU7922300A AU7922300A AU 7922300 A AU7922300 A AU 7922300A AU 79223/00 A AU79223/00 A AU 79223/00A AU 7922300 A AU7922300 A AU 7922300A AU 7922300 A AU7922300 A AU 7922300A
Authority
AU
Australia
Prior art keywords
microarray
diagnosis kit
determining human
detoxification capacity
human detoxification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79223/00A
Inventor
Stefanie Waschutza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere Diagnostics GmbH
Original Assignee
Adnagen GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adnagen GmbH filed Critical Adnagen GmbH
Publication of AU7922300A publication Critical patent/AU7922300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
AU79223/00A 1999-11-16 2000-10-25 Diagnosis kit, method and microarray for determining human detoxification capacity Abandoned AU7922300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19955024 1999-11-16
DE19955024A DE19955024C2 (en) 1999-11-16 1999-11-16 Diagnostic Kit
PCT/EP2000/010478 WO2001036670A2 (en) 1999-11-16 2000-10-25 Diagnosis kit, method and microarray for determining human detoxification capacity

Publications (1)

Publication Number Publication Date
AU7922300A true AU7922300A (en) 2001-05-30

Family

ID=7929173

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79223/00A Abandoned AU7922300A (en) 1999-11-16 2000-10-25 Diagnosis kit, method and microarray for determining human detoxification capacity

Country Status (6)

Country Link
EP (1) EP1230386A2 (en)
JP (1) JP2003517147A (en)
AU (1) AU7922300A (en)
CA (1) CA2388563A1 (en)
DE (1) DE19955024C2 (en)
WO (1) WO2001036670A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10219373A1 (en) * 2002-04-30 2004-02-19 Adnagen Ag Diagnostic kit, useful for assessing a subject's tolerance of drugs, comprises reagents for determining alleles of genes encoding detoxification enzymes
DE10246339A1 (en) * 2002-10-04 2004-04-15 Adnagen Ag Predicting risk, and diagnosis, of chemical-induced disease, e.g. chronic fatigue syndrome, comprises determining allelic status of genes involved in the detoxification process
EP3385393A1 (en) * 2017-04-05 2018-10-10 Eckart Schnakenberg In vitro method for diagnosing of a person's risk for developing an aerotoxic syndrome and kit for carrying out the method
CN107475397A (en) * 2017-09-06 2017-12-15 江苏省疾病预防控制中心 A kind of method and its kit for detecting susceptible occupational noise deaf gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19738908B4 (en) * 1997-09-05 2004-01-29 Adnagen Gmbh Procedure for determining individual genetic influences for pollutant effects and / or planning a therapy concept for people at risk or suffering from neurodermatitis and / or asthma
US5919627A (en) * 1997-10-29 1999-07-06 Incyte Pharmaceuticals, Inc. Microsomal glutathione-S-transferase
AU766544B2 (en) * 1998-06-06 2003-10-16 Genostic Pharma Limited Probes used for genetic profiling

Also Published As

Publication number Publication date
WO2001036670A2 (en) 2001-05-25
JP2003517147A (en) 2003-05-20
CA2388563A1 (en) 2001-05-25
DE19955024C2 (en) 2003-01-16
EP1230386A2 (en) 2002-08-14
DE19955024A1 (en) 2001-06-13
WO2001036670A3 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
AU5788300A (en) Medical treatment method and kit
AU1749700A (en) Methods and articles for regenerating living tissue
AU2001243273A1 (en) System and method for diagnosing pathologic heart conditions
AU2001288249A1 (en) Biosensors and methods for their use
AU2001286902A1 (en) Patient analysis and risk reduction system and associated methods
AU5991500A (en) Apparatus for performing rotating figures or body exercises, and associated gripmember
AU1465801A (en) Methods for cancer prognosis and diagnosis
EP1082466A4 (en) Method, reagent and kit for genotyping of human papillomavirus
AU2002303234A1 (en) Methods and apparatus for discovering, identifying and comparing biological activity mechanisms
AU1138699A (en) Dna demethylase, therapeutic and diagnostic uses thereof
AU7922300A (en) Diagnosis kit, method and microarray for determining human detoxification capacity
AU3460800A (en) Method of bleaching blood samples, diagnostic method and diagnostic kit using the same
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor
AU2001266359A1 (en) Talented person diagnosis supporting method, and talented person diagnosis supporting system
AU6835300A (en) Diagnostic kit and use thereof
AU2034501A (en) Capacity testing method and arrangement
AU5394200A (en) Method and kit for ligand assay
AU2002319080A1 (en) Method for the diagnosis and therapy of renal cell carcinoma
AU6509698A (en) Methods for clinical diagnosis
AU2001263793A1 (en) Kit, method and microarray for determining the sex of a human foetus
EP1044212A4 (en) Human fk506 binding proteins
AU7304000A (en) Virulence gene and protein, and their use
GB9824569D0 (en) Virulence gene and protein,and their use
GB9926345D0 (en) Virulence gene and protein, and their use
GB9926351D0 (en) Virulence gene and protein, and their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase